Potentiation of temozolomide and BCNU cytotoxicity by O6-benzylguanine: A comparative study in vitro

British Journal of Cancer

Volumn 73, Issue 4, 1996, Pages 482-490

  Wedge, S R ^a   Porteous, J K ^a   May, B L ^a   Newlands, E S ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

BCNU; O6 alkylguanine DNA alkyltransferase; O6 benzylguanine; Temozolomide

Indexed keywords

6 O ALKYLGUANINE DNA ALKYLTRANSFERASE; 6 O BENZYLGUANINE; ALKYLATING AGENT; CARMUSTINE; GUANINE; TEMOZOLOMIDE;

ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; CYTOTOXICITY; DNA METHYLATION; DRUG ACTIVITY; DRUG POTENTIATION; DRUG RESISTANCE; ENZYME ACTIVITY; GLIOBLASTOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0030022069     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.85     Document Type: Article

References (96)

1. 6-alkylguanine-DNA alkyltransferase activity potentiates cytotoxicity and induction of SCEs in human glioma cells resistant to 1,3-bis(chloroethyl)-1-nitrosourea. Carcinogenesis, 8, 1219-1223.
2. ALI-OSMAN F. (1989). Quenching of DNA cross-link precursors of chloroethylnitrosoureas and attenuation of DNA interstrand cross-linking by glutathione. Cancer Res., 49, 5258-5261.
3. 6-alkylguanine-DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumour cells. Br. J. Cancer, 67, 1299-1302.
4. BAKER RM, VAN VOORHIS WC AND SPENCER LA. (1979). HeLa cell variants that differ in sensitivity to monofunctional alkylating agents with independence of cytotoxic and mutagenic responses. Proc. Natl Acad. Sci. USA, 76, 5249-5253.
5. BODELL WJ, GEROSA M, AIDA T, BERGER MS AND ROSENBLUM ML. (1985). Investigation of resistance to DNA cross-linking agents in 9L cell lines with different sensitivities to chloroethylnitrosoureas. Cancer Res., 45, 3460-3464.
6. BRADFORD MM. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principles of protein-dye binding. Anal. Biochem., 62, 248-254.
7. BRANCH P, AQUILINA G, BIGNAMI M AND KARRAN P. (1993). Defective mismatch binding and a mutator phenotype in cells tolerant to DNA damage. Nature, 362, 652-654.
8. BRANCH P, HAMPSON R AND KARRAN P. (1995). DNA mismatch binding defects, DNA damage tolerance, and mutator phenotypes in human colorectal carcinoma cell lines. Cancer Res., 55, 2304-2309.
9. 6-alkylguanine-DNA alkyltransferase by alkylating agents or alkylated DNA. Cancer Res., 46, 2320-2323.
10. 6-Alkylguanine-DNA alkyltransferase activity correlates with the therapeutic response of human rhabdomyosarcoma xenografts to 1-(2-chloroethyl)-3-(trans-4-methyl cyclohexyl)-1-nitrosourea. Proc. Natl Acad. Sci. USA, 82, 2985-2989.
11. 6-alkylguanine-DNA alkyltransferase purified from human leukemic lymphoblasts. Cancer Res., 41, 3384-3387.
12. CARTER SK AND WASSERMAN TH. (1976). The nitrosoureas: thoughts for the future. Cancer Treat. Rep., 60, 807-811
13. CATAPANO CV, BROGGINI M, ERBA E, PONTI M, MARIANI L, CITTI L AND D'INCALCI M. (1987). In vitro and in vivo methazolastone-induced DNA damage and repair in L1210 leukemia sensitive and resistant to chloroethylnitrosoureas. Cancer Res., 47, 4884-4889.
14. 6-Methylguanine in DNA inhibits replication in vitro by human cell extracts. Biochemistry, 32, 13664-13672.
15. CESARONE C, BOLOGNESI C AND SANTI L. (1987). Improved microfluorometric DNA determination in biological material using 33258 Hoechst. Anal. Biochem., 102, 188-197.
16. 6-Methylguanine-DNA methyltransferase in human normal and tumour tissue from brain, lung and ovary. Cancer Res., 51, 4131-4134.
17. DENNY BJ, WHEELHOUSE RT, STEVENS MFG, TSANG LLH AND SLACK JA. (1994). NMR and molecular modeling investigation of the mechanism of activation of the antitumour drug temozolomide and its interaction with DNA. Biochemistry, 33, 9045-9051.
18. 6-Methylguanine and temozolomide can reverse the resistance to chloroethylnitrosoureas of a mouse L1210 leukemia. Anticancer Res., 11, 115-122.
19. 6-alkylguanines increases sensitivity to the cytotoxic effects of alkylating agents. Biochem. Biophys. Res. Commun., 132, 178-185.
20. 6-alkylguanines. Cancer Res., 45, 6413-6417.
21. 6-benzylguanine analogues on sensititivity of human tumour cells to the cytotoxic effects of alkylating agents. Cancer Res., 51, 3367-3372.
22. 6-methylguanine on interstrand cross-link formation by ehloroethylnitrosoureas and 2-chloroethyl(methylsulfonyl)-methanesulfonate. Cancer Res., 48, 3603-3606.
23. 6-benzylguanine on the sensitivity of human colon tumour xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). Biochem. Pharmacol. 46, 285-290.
24. 6-methylguanine-DNA-methyltransferase activity and resistance of human cells to the cytotoxic and mutagenic effect of N-methyl-N-nitro-N-nitrosoguanidine. Carcinogenesis, 5, 1641-1647.
25. DRUMMOND JT, LI GM, LONGLEY MJ AND MODRICH P. (1995). Isolation of an hMSH2-p160 heterodimer that restores DNA mismatch repair to tumor cells. Science, 268, 1909-1912.
26. EDWARDS MS, LEVIN VA AND WILSON CB. (1980). Brain tumour chemotherapy: an evaluation of agents in current use for phase II and III trials. Cancer Treat. Rep., 64, 1179-1205.
27. ERICKSON LC, LAURENT G, SHARKEY NA AND KOHN KW. (1980). DNA cross-linking and monoadduct repair in nitrosourea-treated human tumour cells. Nature, 288, 727-729.
28. 6-benzylguanine increases the sensitivity of human primary bone marrow cells to the cytotoxic effects of temozolomide. Exp. Haematol., 23, 112-116.
29. 6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Chemother. Pharmcol., 32, 471-476.
30. FISHEL R, LESCOE MK, RAO MRS, COPELAND NG, JENKINS NA, GARBER J, KANE M AND KOLODNER R. (1993). The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis cancer. Cell, 75, 1027-1038.
31. FRIEDMAN HS, DOLAN ME, MOSCHEL RC, PEGG AE, FELKER GM, RICH J, BIGNER DD, SCHOLD JR SC. (1992). Enhancement of nitrosourea activity in medulloblastoma and glioblastoma multiforme. J. Natl Cancer Inst., 84, 1926-1931.
32. 6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in a human colon cancer xenograft completely resistant to BCNU alone. Biochem. Pharmacol., 45, 483-491.
33. 6-alkylguanine-DNA alkyltransferase activity based on cellular DNA content in human, rat and mouse tissues. Carcinogenesis, 7, 745-749.
34. 6-alkylguanine-DNA alkyltransferase. Cancer Res., 48, 1521-1527.
35. 6-methylguanine. Biochem. Pharmacol., 43, 1101-1107.
36. + phenotype. Cancer Res., 46, 4995-4998.
37. GOLDMACHER VS, CUZICK RA AND THILLY WG. (1986). Isolation and partial characterization of human cell mutants differing in sensitivity to killing and mutation by methylnitrosourea and N-methyl-N-nitro-N-nitroguanidine. J. Biol. Chem., 261, 12462-12471.
38. 6-methylguanine-DNA methyltransferase and chloroethylnitrosourea-treated DNA. Cancer Res., 52, 6052-6058.
39. - cells. Carcinogenesis, 8, 1449-1453.
40. GRIFFIN S AND KARRAN P. (1993). Incision at DNA GT mispairs by extracts of mammalian cells occurs preferentially at cytosine methylation sites and is not targeted by a separate GT binding reaction. Biochemistry, 32, 13032-13039.
41. GRIFFIN S, BRANCH P, XU Y AND KARRAN P. (1994). DNA mismatch binding and incision at modified guanine bases by extracts of mammalian cells: implications for tolerance to DNA methylation damage. Biochemistry, 33, 4787-4793.
42. GRILLEY M, WELSH KM, SU SS AND MODRICH P. (1989). Isolation and characterization of the Escherichia coli mutL gene product. J. Biol. Chem., 264, 1000-1004.
43. HAYWARD IP AND PARSONS PG. (1984). Comparison of virus reactivation, DNA base damage, and cell cycle effects in autologous human melanoma cells resistant to methylating agents. Cancer Res., 44, 55-58.
44. HOLMES J, CLARK S AND MODRICH P. (1990). Strand-specific mismatch correction in nuclear extracts of human and Drosophila melanogaster cell lines. Proc. Natl Acad. Sci. USA, 87, 5837-5841.
45. JIANG B, BAWR B, HSIANG Y, SHEN T, POTMESIL M AND SILBER R. (1989). Lack of drug-induced DNA cross-links in chlorambucil-resistant Chinese Hamster Ovary cells. Cancer Res., 49, 5514-5517.
46. JIRICNY J, HUGHES M, CORMAN N AND RUDKIN BB. (1988). A human 200-kDa protein binds selectively to DNA fragments containing GT mismatches. Proc. Natl Acad. Sci. USA, 85, 8860-8864.
47. KARRAN P AND BIGNAMI M. (1992). Self-destruction and tolerance in resistance of mammalian cells to alkylation damage. Nucleic Acids Res., 20, 2933-2940.
48. 6-Methylguanine residues elicit DNA repair synthesis by human cell extracts. J. Biol. Chem., 268, 15878-15886.
49. KAT A, THILLY WG, FANG WH, LONGLEY MJ, LI GM AND MODRICH P. (1993). An alkylation-tolerant, mutator cell line is deficient in strand-specific mismatch repair. Proc. Natl Acad. Sci. USA, 90, 6424-6428.
50. 6-alkylguanine-DNA alkyltransferase depletion and regeneration in human peripheral lymphocytes following Dacarbazine and Fotemustine. Cancer Res., 51, 619-623.
51. 6-alkylguanine-DNA alkyltransferase in human peripheral blood mononuclear cells by temozolomide. Br. J. Cancer, 69, 452-456.
52. LI G-M AND MODRICH P. (1995). Restoration of mismatch repair to nuclear extracts of H6 colorectal tumour cells by a heterodimer of human MutL homologs. Proc. Natl Acad. Sci. USA, 92, 1950-1954.
53. 6-methylguanine-DNA adducts protects transgenic mice from N-methylnitrosourea-induced thymic lymphomas. Cancer Res., 54, 4648-4652.
54. LOWN JW, MCLAUGHLIN LW AND CHANG YM. (1978). Mechanism of action of 2-haloethylnitrosoureas on DNA and its relation to their antileukemic properties. Bioorg. Chem., 7, 97-110.
55. 6-benzylguanine with or without streptozotocin enhances 1,3-bis(2-chloroethyl)-1-nitrosourea sensitivity in vitro. Cancer Res., 53, 4281-4286.
56. 6-benzylguanine combined with streptozotocin treatment enhances 1,3-bis(2-chloroethyl)-1-nitrosourea cytotoxicity. Cancer Res., 54, 4371-4375.
57. MARGISON GP AND O'CONNOR PJ. (1990). Biological consequences of reactions with DNA: Role of specific lesions. Chemical Carcinogenesis and Mutagenesis. In Handbook of Experimental Chemotherapy, Grover PL and Phillips DH (eds), pp 547-571, Springer: Heidelberg.
58. 6-benzylguanine on the sensitivity of human tumour xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea and on DNA interstrand cross-link formation. Cancer Res., 52, 1171-1175.
59. 6-alkylguanine-DNA alkyltransferase activity and sensitivity of human tumour cells and xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Chemother. Pharmacol., 32, 59-63.
60. 6-substituted guanine-induced mutagenesis of ras oncogenes. Proc. Natl Acad. Sci. USA, 86, 8650-8654.
61. MOERTEL GG. (1973). Therapy of advanced gastrointestinal cancer with the nitrosoureas. Cancer Chemother. Rep., 4, 27-32.
62. MONTGOMERY JA, JAMES R, MCCALEB GS AND JOHNSTON TP. (1967). The modes of decomposition of 1,3-bis(2-chloroethyl)-1-nitrosourea and related compounds. J. Med. Chem., 10, 668-674.
63. NEWLANDS ES, BLACKLEDGE G, SLACK JA. GODDARD C, BRINDLEY CJ, HOLDEN L AND STEVENS MFG. (1985). Phase I clinical trial of mitozolomide. Cancer Treat. Rep., 69, 801-805.
64. NEWLANDS ES, BLACKLEDGE GRP, SLACK JA, RUSTIN GJS, SMITH DB, STUART NSA, QUARTERMAN CP, HOFFMAN R, STEVENS MFG, BRAMPTON MH AND GIBSON AC. (1992). Phase I trial of temozolomide (CCRG 81045: M & B 39831: NSC 362856). Br. J. Cancer, 65, 287-291.
65. O'REILLY SM, NEWLANDS ES, GLASER MG, BRAMPTON M, RICE EDWARDS JM, ILLINGWORTH RD, RICHARDS PG, KENNARD C, COLQUHOUN IR, LEWIS P AND STEVENS MFG. (1993). Temozolomide: a new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours. Eur. J. Cancer, 29A 940-942.
66. PALOMBO F, HUGHES M, JIRICNY J, TRUONG O AND HSUAN J. (1994). Mismatch repair and cancer. Nature, 367, 417.
67. PALOMBO E, GALLINARI P, IACCARINO I, LETTIERI T, HUGHES M, D'ARRIGO A, TRUONG O, HSUAN JJ AND JIRICNY J. (1995). GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells. Science. 268, 1912-1914.
68. 6-alkylguanine-DNA alkyltransferase-mediated Carmustine resistance using Steptozotocin: a phase I trial. Cancer Res., 52, 2456-2459.
69. PAPADOPOULOS N, NICOLAIDES NC, LIU B, PARSONS R, LENGAUER C, PALOMBO F, D'ARRIGO A, MARKOWITZS, WILLSON JKV, KINZLER KW, JIRICNY J AND VOGELSTEIN B. (1995). Mutations of GTBP in genetically unstable cells. Science, 268, 1915-1917.
70. + tumour cells. Cell, 75, 1227-1236.
71. PEGG AE. (1993). Alkylation and subsequent repair of DNA after exposure to dimethylnitrosamine and related carcinogens. Rev. Biochem. Toxicol., 5, 83-133.
72. 6-alkylguanine-DNA alkyltransferase. Cancer Res., 44, 3806-3811.
73. PIEPER RO, FUTSCHER BW AND ERICKSON LC. (1989). Transcription termination lesions induced by bifunctional alkylating agents in vitro. Carcinogenesis, 10, 1307-1314.
74. PLANT JE AND ROBERTS JJ. (1971). Extension of the pre-DNA synthetic phase of the cell cycle as a consequence of DNA alkylation in Chinese hamster cells: a possible mechanism of DNA repair. Chemico-Biol. Interact., 3, 343-351.
75. PLOWMAN J, WAUD WR, KOUTSOUKOS AD, RUBINSTEIN LV, MOORE TD AND GREVER MR. (1994). Preclinical antitumour activity of temozolomide in mice: efficacy against brain tumour xenografts and synergism with 1,3-bis-(2-chloroethyl)-1-nitrosourea. Cancer Res., 54, 3793-3799.
76. POTTER DW AND REED DJ. (1983). Involvement of FMN and phenobarbital cytochrome P-450 in stimulating a one electron reductive denitrosation of 1-(2-chloroethyl)-3-(cyclohexyl)-1-nitrosourea catalysed by NADPH-cytochrome P-450 reductase. J. Biol. Chem., 258, 6906-6911.
77. 6-alkylguanine-DNA alkyltransferase as potential indicators of constitutive drug resistance in human colorectal tumours. Cancer Res., 51, 2092-2097.
78. 6-benzylguanine and hypoxia on the cytotoxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea in nitrosourea-resistant SF-763 cells. Cancer Chemother. Pharmacol., 32, 477-481.
79. SCUDIERO DA, MEYER SA, CLATTERBUCK BE, MATTERN MR, ZIOLKOWSKI CHJ AND DAY RS III. (1984). Relationship of DNA repair phenotypes of human fibroblast and tumour strains to killing by N-methyl-N-nitro-N-nitrosoguanidine. Cancer Res., 44, 961-969.
80. SEIDENFELD J, BARNES D, BLOCK AL AND ERICKSON LC. (1987). Comparison of DNA intrastrand cross-linking and strand breakage by 1,3-bis(2-chloroethyl)-1-nitrosourea in polyamine-depleted and control human adenocarcinoma cells. Cancer Res., 47, 4538-4543.
81. SHIBATA D, PEINADO MA, IONOV Y, MALKHOSYAN S AND PERUCHO M. (1994). Genomic instability in repeated sequences is an early somatic event in colorectal tumorigenesis that persists after transformation. Nature Genet., 6, 273-281.
82. 6-alkylguanine DNA-alkyltransferase is not a major determinant of sensitivity to 1.3-bis(2-chloroethyl)-1-nitrosourea in four medulloblastoma cell lines. Oncology Res., 4, 241-248.
83. SKEHAN P, STORENG R, SCUDIERO D, MONKS A, MCMAHON J, VISTICA D, WARREN JT, BOKESCH H, KENNEY S AND BOYD MR. (1990). New colorimetric assay for anti-cancer drug screening. J. Natl Cancer Inst., 82, 1107-1118.
84. SMITH MT, EVANS CG, DOANE-SETZER P, CASTRO VM, TAHIR MK AND MANNERVIK B. (1989). Denitrosation of 1,3-bis(2-chloroethyl)-1-nitrosourea by class μ glutathione transferases and its role in cellular resistance in rat brain tumour cells. Cancer Res., 49 2621-2625.
85. SU SS AND MODRICH P. (1986). Escherichia coli mutS-encoded protein binds to mismatched DNA base pairs. Proc. Natl Acad. Sci. USA, 83, 5057-5061.
86. 6-alkylguanine. Proc. Natl Acad. Sci. USA, 87, 686-690.
87. 6 alkylation in the mechanism of cytotoxicity of imidazotetrazinones. Biochem. Pharmacol., 36, 457-462.
88. 1-bis[2-chloroethyl]-N-nitrosourea). Biochem. Biophys. Res. Commun., 100, 351-357.
89. 1-bis(2-chloroethyl)-N-nitrosourea (BCNU). Cancer Res., 42, 3102-3105.
90. UMAR A, BOYER JC, THOMAS DC, NGUYEN DG, RISINGER JI, BOYD J, IONOV Y, PERUCHO M AND KUNKEL T. (1994). Defective mismatch repair in extract of colorectal and endometrial cell lines exhibiting microsatellile instability. J. Biol. Chem., 269, 14367-14370.
91. WALKER MD AND HURWTTZ BS. (1970). BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea: NSC 409962) in the treatment of malignant brain tumours. A preliminary report. Cancer Chemother. Rep., 54, 263-271.
92. WEINKAM RJ AND LIN HS. (1979). Reactions of BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea) and CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) in aqueous solution. J. Med. Chem., 22, 1193-1198.
93. 6-methylguanine-DNA methyltransferase in Chinese Hamster Ovary cells. Cancer Res., 54, 3857-3863.
94. 6-methylguanine-DNA methyltransferase in cell survival, mutagenesis and carcinogenesis. Mutat. Res., 145, 1-16.
95. YOUNG RC, DEVITA VT JR, SERPICK AA AND CANELLOS CP. (1971). Treatment of advanced Hodgkin's disease with [1,3-bis(2-chloroethyl)-1-nitrosourea] BCNU., N. Engl J. Med., 285, 475-479.
96. ZOUBOULlS C, GARBE C AND ORFANOS CE. (1989). Factors influencing the in vitro growth of human melanoma cell lines. Skin Cancer, 4, 63-72.